Cancer Patient Pathways (CPPs) were introduced in 2000–2015 in several European countries, including Denmark, to reduce the time to diagnosis and treatment initiation and ultimately improve patient survival. Yet, the prognostic consequences of implementing CPPs remain unknown for symptomatic cancer patients diagnosed through primary care. | Prognostic consequences of implementing cancer patient pathways in Denmark A comparative cohort study of symptomatic cancer patients in primary care
